Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation

Conclusion: Everolimus is effective as treatment for CLAD since it improves the loss of FEV1. We also observed an improvement of other laboratory parameters like creatinine.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Iturbe Fernandez, D., De Pablo Gafas, A., Escobar Ramirez, K. F., Ruiz Sainz, F., Perez Gonzalez, V., Mora Cuesta, V. M., Fernandez Rozas, S. M., Alonso Moralejo, R., Cifrian Martinez, J. M. Tags: Transplantation Source Type: research